204 related articles for article (PubMed ID: 7299540)
1. Chelation therapy in beta-thalassemia major. III. The role of splenectomy in achieving iron balance.
Graziano JH; Piomelli S; Hilgartner M; Giardina P; Karpatkin M; Andrew M; LoIacono N; Seaman C
J Pediatr; 1981 Nov; 99(5):695-9. PubMed ID: 7299540
[TBL] [Abstract][Full Text] [Related]
2. Intensive iron chelation therapy in beta-thalassemia major: some effects on iron metabolism and blood transfusion dependence.
Silvestroni E; Bianco I; Graziani B; Lerone M; Valente M; Congedo P; Ponzini D; Costantini S
Acta Haematol; 1982; 68(2):115-23. PubMed ID: 6812366
[TBL] [Abstract][Full Text] [Related]
3. Chelation therapy, transfusion requirement, and iron balance in young thalassemic patients.
Piomelli S; Graziano J; Karpatkin M; Dudell GG; Hart D; Hilgartner M; Khanna K; Valdes-Cruz LM; Vora S
Ann N Y Acad Sci; 1980; 344():409-17. PubMed ID: 6930881
[No Abstract] [Full Text] [Related]
4. Long-term effect of splenectomy on transfusion requirements in thalassemia major.
Cohen A; Gayer R; Mizanin J
Am J Hematol; 1989 Apr; 30(4):254-6. PubMed ID: 2929586
[TBL] [Abstract][Full Text] [Related]
5. Iron metabolism in thalassemia intermedia.
Fiorelli G; Fargion S; Piperno A; Battafarano N; Cappellini MD
Haematologica; 1990; 75 Suppl 5():89-95. PubMed ID: 2086386
[TBL] [Abstract][Full Text] [Related]
6. [Chelating therapy in beta-thalassemia].
Musumeci S; Romeo MA; Di Gregorio F; Schiliró G; Russo G
Pediatr Med Chir; 1982; 4(1-2):55-9. PubMed ID: 7111040
[TBL] [Abstract][Full Text] [Related]
7. Prolonged survival in patients with beta-thalassemia major treated with deferoxamine.
Ehlers KH; Giardina PJ; Lesser ML; Engle MA; Hilgartner MW
J Pediatr; 1991 Apr; 118(4 Pt 1):540-5. PubMed ID: 2007928
[TBL] [Abstract][Full Text] [Related]
8. Reduction of iron overload in thalassemia.
Piomelli S; Graziano J
Birth Defects Orig Artic Ser; 1982; 18(7):339-46. PubMed ID: 7159742
[No Abstract] [Full Text] [Related]
9. [Monitoring and appraisal of the effects of blood transfusion and iron chelation in thalassemia major].
Girot R; Triadou P; Bories D; Jeannel F; Thevenin M; Rymer JC
Nouv Rev Fr Hematol (1978); 1982; 24(5):281-7. PubMed ID: 7167380
[TBL] [Abstract][Full Text] [Related]
10. Clinical management of beta-thalassemia.
Graziano J; Piomelli S
Tex Rep Biol Med; 1980-1981; 40():355-64. PubMed ID: 7034276
[No Abstract] [Full Text] [Related]
11. High transfusion in children with beta-thalassemia/Hb E: clinical and laboratory assessment of 18 cases.
Torcharus K; Withayathawornwong W; Sriphaisal T; Krutvacho T; Arnutti P; Suwanasophorn C
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():96-9. PubMed ID: 7886617
[TBL] [Abstract][Full Text] [Related]
12. Iron overload and desferrioxamine chelation therapy in beta-thalassemia intermedia.
Cossu P; Toccafondi C; Vardeu F; Sanna G; Frau F; Lobrano R; Cornacchia G; Nucaro A; Bertolino F; Loi A; De Virgiliis S; Cao A
Eur J Pediatr; 1981 Nov; 137(3):267-71. PubMed ID: 7318837
[TBL] [Abstract][Full Text] [Related]
13. Combined subcutaneous and high-dose intravenous deferoxamine therapy of thalassemia.
Hyman CB; Agness CL; Rodriguez-Funes R; Zednikova M
Ann N Y Acad Sci; 1985; 445():293-303. PubMed ID: 3860133
[TBL] [Abstract][Full Text] [Related]
14. Treatment of iron overload in Cooley's anemia.
Cohen A; Mizanin J; Schwartz E
Ann N Y Acad Sci; 1985; 445():274-81. PubMed ID: 3860130
[No Abstract] [Full Text] [Related]
15. Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review.
Delea TE; Edelsberg J; Sofrygin O; Thomas SK; Baladi JF; Phatak PD; Coates TD
Transfusion; 2007 Oct; 47(10):1919-29. PubMed ID: 17880620
[TBL] [Abstract][Full Text] [Related]
16. Iron chelation therapy with deferoxamine in Cooley anemia.
Cohen A; Schwartz E
J Pediatr; 1978 Apr; 92(4):643-7. PubMed ID: 633031
[TBL] [Abstract][Full Text] [Related]
17. Desferrioxamine induced urinary iron excretion in thalassemia.
Dubey AP; Kumar S; Choudhury P; Talukdar B; Puri RK
Indian Pediatr; 1993 Jun; 30(6):775-8. PubMed ID: 8132258
[TBL] [Abstract][Full Text] [Related]
18. Reassessment of the use of desferrioxamine B in iron overload.
Propper RD; Shurin SB; Nathan DG
N Engl J Med; 1976 Jun; 294(26):1421-3. PubMed ID: 1272274
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of iron balance in homozygous beta-thalassemia subjects treated with desferrioxamine administered subcutaneously].
Ferrara M; Galdo Capotorti M; Ponte G; Esposito L
Pediatria (Napoli); 1983; 91(4):371-7. PubMed ID: 6545400
[No Abstract] [Full Text] [Related]
20. Cooley anemia: high transfusion regimen and chelation therapy, results, and perspective.
Weiner M; Karpatkin M; Hart D; Seaman C; Vora SK; Henry WL; Piomelli S
J Pediatr; 1978 Apr; 92(4):653-8. PubMed ID: 633033
[No Abstract] [Full Text] [Related]
[Next] [New Search]
